FDA’s bilateral and multilateral interactions with Mexico and the countries of Central America, South America, and the Caribbean are to ensure that the entire range of FDA-regulated products developed, tested, manufactured, grown and/or processed from this region and are exported to the U.S. meet FDA requirements. FDA’s efforts focus primarily on food and animal feed safety protection issues, medical product safety issues, and regulatory oversight of clinical trials, as well as product manufacturing quality. Among the many challenges facing the FDA in the region include the wide geographic diversity and area covered by Latin America, the diversity of product issues and the wide range of sophistication of the regulatory authorities in the region.
Safety of Drug Residues in Animals Destined for Human Consumption FDA Team Expert in Norovirus Supports the ISP with Methodologies for the Detection of the Virus FDA Expands Presence Outside U.S. with Opening of Mexico City Post HHS-FDA Launches first-event Workshop on Good Clinical Practices in the Americas
Recalls & Alerts
U.S. Food and Drug Administration
Office of International Programs
Latin America Office
3440 San Jose PlaceWashington, DC 20521-3440